Found 8 matching trials
Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg PHASE1 The objective of this study was to investigate the bioequivalence of Mylan'...
Show More Location
Kendle International Inc.
Learn More & Join Trial
Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions PHASE1 This study will compare the relative bioavailability of 500 mg Divalproex S...
Show More Location
PRACS Institute, Ltd.
Learn More & Join Trial
Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness PHASE4 The purpose of this study is to assess the efficacy and safety of continued...
Show More Location
Behavioral and Medical Research, LLC
Learn More & Join Trial
To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions PHASE1 To demonstrate the relative bioavailability of Divalproex Sodium 500 mg del...
Show More Location
Multiple Locations
Learn More & Join Trial
Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions PHASE1 The purpose of this study is to demonstrate the bioequivalence of divalproe...
Show More Location
Multiple Locations
Learn More & Join Trial
Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg PHASE1 The objective of this study was to investigate the bioequivalence of Mylan'...
Show More Location
Kendle International Inc.
Learn More & Join Trial
Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions PHASE1 This study will compare the relative bioavailability of 500 mg Divalproex S...
Show More Location
PRACS Institute Ltd.
Learn More & Join Trial
To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions PHASE1 To demonstrate the relative bioavailability of Divalproex Sodium 500 mg del...
Show More Location
Multiple Locations
Learn More & Join Trial